Companies
- Companies
- Company details
PhytoHealth Corp
Out-licensing
Phase I/II Clinical Development of a Novel Botanical Extract for Hepatitis C Treatment More
Phase II Clinical Development of PHN031: Phytotherapeutic for the Treatment of Osteoporosis More
Phase III Clinical Development of PHN011/012/013 (PG2): Prophylaxis of Neutropenia More
PhytoHealth Begins Bioavailability/Pharmacokinetic Study of PHN021 (PCNH): A New Chemical Entity for the Prevention of Motion Sickness without Causing Drowsiness More
PhytoHealth Completes Patient Enrolment in Phase II Clinical Trial of PHN081 (PDC-748): An Antitussive New Drug Candidate More
Related Reports
Market Research Reports provided by reports.iptechex.com
Nov 2010 - 29 pages - $500
May 2011 - 25 pages - $250
Nov 2010 - 101 pages - $600
Jul 2010 - 28 pages - $750
Feb 2011 - 13 pages - $99
Jul 2010 - 17 pages - $99
Feb 2010 - 17 pages - $99
Feb 2011 - 19 pages - $99
Jan 2011 - 24 pages - $99
Nov 2010 - 25 pages - $99
Contact details
T. S. Jiang
Head office
© Copyright 1998-2013 IP Technology Exchange, Inc All rights reserved. Terms and Conditions | Contact us